Eli Lilly (LLY) Net Income (2009 - 2026)

Eli Lilly (LLY) has reported Net Income for 17 consecutive years, with $7.4 billion the latest figure, recorded in Q1 2026.

• Net Income for Q1 2026 came in at $7.4 billion, up 168.07% year-over-year; the trailing twelve-month figure through Mar 2026 was $25.3 billion (up 127.59% YoY), and the FY2025 annual result was $20.6 billion, up 94.9% from the prior year.
• Net Income was $7.4 billion for Q1 2026 at Eli Lilly, up from $6.6 billion in the prior quarter.
• Over five years, Net Income peaked at $7.4 billion in Q1 2026 and troughed at -$57.4 million in Q3 2023.
• Average Net Income over 5 years is $2.9 billion, with a median of $2.2 billion recorded in 2023.
• Year-over-year, Net Income tumbled 103.95% in 2023 and jumped 1790.42% in 2024.
• Over 5 years, Net Income stood at $1.9 billion in 2022, then rose by 12.98% to $2.2 billion in 2023, then surged by 101.43% to $4.4 billion in 2024, then jumped by 50.52% to $6.6 billion in 2025, then advanced by 11.42% to $7.4 billion in 2026.
• Per Business Quant data, the three most recent Net Income figures were $7.4 billion in Q1 2026, $6.6 billion in Q4 2025, and $5.6 billion in Q3 2025.